Inozyme Pharma, Inc. (INZY)
NASDAQ: INZY · Real-Time Price · USD
0.9244
-0.0374 (-3.89%)
At close: Apr 17, 2025, 4:00 PM
0.9450
+0.0206 (2.23%)
After-hours: Apr 17, 2025, 4:37 PM EDT
Inozyme Pharma Market Cap
Inozyme Pharma has a market cap or net worth of $59.07 million as of April 17, 2025. Its market cap has decreased by -86.66% in one year.
Market Cap
59.07M
Enterprise Value
-7.15M
1-Year Change
-86.66%
Ranking
Category
Stock Price
$0.92
Market Cap Chart
Since July 24, 2020, Inozyme Pharma's market cap has decreased from $356.32M to $59.07M, a decrease of -83.42%. That is a compound annual growth rate of -31.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2025 | 59.07M | -66.81% |
| Dec 31, 2024 | 177.95M | -32.37% |
| Dec 29, 2023 | 263.10M | 520.31% |
| Dec 30, 2022 | 42.41M | -73.72% |
| Dec 31, 2021 | 161.39M | -66.54% |
| Dec 31, 2020 | 482.42M | 35.39% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 754.27B |
| UnitedHealth Group | 415.38B |
| Johnson & Johnson | 379.48B |
| AbbVie | 306.02B |
| Novo Nordisk | 284.50B |
| Abbott Laboratories | 227.16B |
| Novartis AG | 209.93B |
| AstraZeneca | 208.11B |